Joseph M Fayad

This inventor holds 7 USPTO granted patents and 10 published patent applications and 1 EPO patent. Top assignees: Volant Holdings Gmbh, Therabrake, Inc.. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph M Fayad. Retrieved from https://idiyas.com/inventor/joseph-m-fayad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 10)

% Patents Active = 85.7

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 35(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2015-2020

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10624913 - Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof (2020-04-21),

2. 10245277 - Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection (2019-04-02),

3. 9757346 - Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes) (2017-09-12),

4. 9730951 - Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infection (2017-08-15),

5. 9443060 - Method and system to provide personalized pharmaceutical compositions and dosages (2016-09-13),

6. 9370528 - Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection (2016-06-21),

7. 8999721 - Method and system to provide personalized pharmaceutical compositions and dosages (2015-04-07),

Title: Joseph M Fayad: Innovator in Hepatic Health Solutions

Introduction

Joseph M Fayad is a prominent inventor based in Las Vegas, NV (US), known for his significant contributions to the field of hepatic health. With a total of 7 patents, Fayad has focused on developing innovative diagnostics and treatment methods for liver-related conditions, particularly non-alcoholic hepatic steatosis and steatohepatitis.

Latest Patents

Fayad's latest patents include groundbreaking work on diagnostics and methods for the treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis. His inventions aim to characterize NASH through a combination of modeling and biomarkers, which enable the development of pharmaceutical compositions and treatment methods. These innovations address the inhibition, resolution, and prevention of Non-Alcoholic Fatty Liver Disease (NAFLD) and its complications. Fayad's work also extends to treating patients with hepatitis viral infections, including Hepatitis B and C, and the associated complications such as cirrhosis and hepatocellular cancer.

Career Highlights

Throughout his career, Joseph M Fayad has worked with notable companies, including Volant Holdings GmbH and Therabrake, Inc. His expertise in hepatic health has positioned him as a key figure in the development of therapeutic solutions for metabolic syndromes and liver diseases.

Collaborations

Fayad has collaborated with esteemed professionals in his field, including Jerome J Schentag and Scott V Monte. These partnerships have further enhanced his research and development efforts in hepatic health.

Conclusion

Joseph M Fayad's innovative work in the field of hepatic health has made a significant impact on the treatment and understanding of liver-related diseases. His contributions continue to pave the way for advancements in medical science and patient care.

Profile summary based on public USPTO records.